According to the latest report by IMARC Group, titled “Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, . Facial injectables are used to enhance the physical appearance of the skin by administering them on specific portions of the face. They are typically produced from collagen, hyaluronic acid, and calcium hydroxyapatite. Facial injectables help in restoring the elasticity of the skin, reduce wrinkles, augment lips, define shallow contours, and fill depressed scars. These injectables are gaining global popularity since they are safe, cost-effective, and require minimal downtime.
Request Free Sample Report: https://www.imarcgroup.com/facial-injectables-market/requestsample
The growing geriatric population, who are more prone to wrinkles, acne, and other skin-related ailments, is primarily driving the demand for facial injectables. Additionally, the rising consumer consciousness towards facial appearances, along with increasing demand for minimally-invasive surgeries, is also augmenting the market growth. Besides this, the growing prevalence of numerous dermatological ailments that occur due to excessive sun exposure and high pollution levels, is further bolstering the product demand. Additionally, the expanding medical tourism sector, along with the increasing number of professional practitioners providing personalized facial injectables as per the consumer’s requirement, will continue to drive the global market. Looking forward, IMARC Group expects the global facial injectables market to exhibit strong growth during the next five years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global facial injectables market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, application type, application and end user.
Breakup by Product Type:
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymethylmethacrylate Beads (PMMA Microspheres)
- Poly-L-Lactic Acid (PLLA)
- Others
Breakup by Application Type:
- Aesthetics
- Therapeutics
Breakup by Application:
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Others
Breakup by End User:
- Hospitals
- Dermatology Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape Key Player:
- Allergan Plc
- Anika Therapeutics Inc.
- Bloomage BioTechnology
- Johnson & Johnson
- Galderma Pharma S.A.
- Integra LifeSciences
- Ipsen (Mayroy SA)
- Medytox Inc.
- Merz Holding GmbH & Co. KG
- Prollenium Medical Technologies Inc.
- Sanofi
- SciVision Biotech Inc.
- Sinclair Pharma (Huadong Medicine Co. Ltd.)
- Suneva Medical Inc.
- Bausch Health Companies Inc
Explore Full Report with TOC & List of Figure:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
